why choose us

First received: September 09, 2022

Clinical Trial: Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: The Validity of Intra-cortical Inhibition as a Biomarker of Cognitive Deficits in Schizophrenia and in Predicting the Efficacy of TMS Treatment

Brief Summary: Cognitive deficit is a core symptom of schizophrenia (SZ), but its pathological mechanism is poorly understood and the treatment effect is poor.The excitatory-inhibitory microcircuit (E-I) function imbalance formed by inhibitory interneurons and excitatory pyramidal cells in the cerebral cortex is a new mechanism of cognitive deficits in SZ discovered in recent years.Cortical E-I is expected to be a new target for the treatment of cognitive deficits in SZ.Paired transcranial magnetic stimulation (ppTMS)-induced…

Read more